Kither Biotech
Pharmaceutical developer specializing in new treatments for chronic inflammatory diseases.
3
Funding Rounds
$46.9m
Money raised
Overview
Pharmaceutical developer specializing in new treatments for chronic inflammatory diseases.
- Websites:
- Business model: B2B
- Headquarters: Turin
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma*** Ke*** Ma****** |
|
- | |
| Em**** Hi**** |
|
- | |
| Al******** Gh*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Kither Biotech has raised a total of $46.9m in funding over 3 rounds.
Key Insights:
- Kither Biotech Series B round, March 2022: $20.6m
- Kither Biotech March 2022 Series B Funding Round: $20m
- Kither Biotech Series A round, July 2019: $6.3m
Kither Biotech Series B round, March 2022
$20.6m
Kither Biotech March 2022 Series B Funding Round
$20m
Kither Biotech Series A round, July 2019
$6.3m
Industries
Kither Biotech is active in the following industries: